Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Jan;79(927):18–24. doi: 10.1136/pmj.79.927.18

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century

M Begbie 1, G Wallace 1, C Shovlin 1
PMCID: PMC1742589  PMID: 12566546

Abstract

Hereditary haemorrhagic telangiectasia (HHT) affects one in 5-8000, and no longer can be viewed as solely causing anaemia (due to nasal and gastrointestinal bleeding) and characteristic mucocutaneous telangiectasia. Arteriovenous malformations commonly occur, and in the pulmonary and cerebral circulations demand knowledge of risks and benefits of asymptomatic screening and treatment. HHT is inherited as an autosomal dominant trait and there is no age cut off when apparently unaffected offspring of an individual with HHT can be told they are unaffected. This review focuses on the evolving evidence base for HHT management, issues regarding pregnancy and prothrombotic treatments, and discusses the molecular and cellular changes that underlie this disease.

Full Text

The Full Text of this article is available as a PDF (181.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AAssar O. S., Friedman C. M., White R. I., Jr The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope. 1991 Sep;101(9):977–980. doi: 10.1288/00005537-199109000-00008. [DOI] [PubMed] [Google Scholar]
  2. Abdalla S. A., Pece-Barbara N., Vera S., Tapia E., Paez E., Bernabeu C., Letarte M. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Hum Mol Genet. 2000 May 1;9(8):1227–1237. doi: 10.1093/hmg/9.8.1227. [DOI] [PubMed] [Google Scholar]
  3. Boillot O., Bianco F., Viale J. P., Mion F., Mechet I., Gille D., Delaye J., Paliard P., Plauchu H. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology. 1999 Jan;116(1):187–192. doi: 10.1016/s0016-5085(99)70243-x. [DOI] [PubMed] [Google Scholar]
  4. Bourdeau A., Cymerman U., Paquet M. E., Meschino W., McKinnon W. C., Guttmacher A. E., Becker L., Letarte M. Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol. 2000 Mar;156(3):911–923. doi: 10.1016/S0002-9440(10)64960-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bourdeau A., Dumont D. J., Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest. 1999 Nov;104(10):1343–1351. doi: 10.1172/JCI8088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buscarini E., Buscarini L., Civardi G., Arruzzoli S., Bossalini G., Piantanida M. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. AJR Am J Roentgenol. 1994 Nov;163(5):1105–1110. doi: 10.2214/ajr.163.5.7976883. [DOI] [PubMed] [Google Scholar]
  7. Caselitz M., Wagner S., Chavan A., Gebel M., Bleck J. S., Wu A., Schlitt H. J., Galanski M., Manns M. P. Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut. 1998 Jan;42(1):123–126. doi: 10.1136/gut.42.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cymerman U., Vera S., Pece-Barbara N., Bourdeau A., White R. I., Jr, Dunn J., Letarte M. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res. 2000 Jan;47(1):24–35. doi: 10.1203/00006450-200001000-00008. [DOI] [PubMed] [Google Scholar]
  9. Dakeishi Miwako, Shioya Takanobu, Wada Yasuhiko, Shindo Tsutomu, Otaka Kousei, Manabe Motomu, Nozaki Jun-Ichi, Inoue Sumiko, Koizumi Akio. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002 Feb;19(2):140–148. doi: 10.1002/humu.10026. [DOI] [PubMed] [Google Scholar]
  10. Feinstein Jeffrey A., Moore Phillip, Rosenthal David N., Puchalski Michael, Brook Michael M. Comparison of contrast echocardiography versus cardiac catheterization for detection of pulmonary arteriovenous malformations. Am J Cardiol. 2002 Feb 1;89(3):281–285. doi: 10.1016/s0002-9149(01)02228-7. [DOI] [PubMed] [Google Scholar]
  11. Fulbright R. K., Chaloupka J. C., Putman C. M., Sze G. K., Merriam M. M., Lee G. K., Fayad P. B., Awad I. A., White R. I., Jr MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998 Mar;19(3):477–484. [PMC free article] [PubMed] [Google Scholar]
  12. Garcia-Tsao G., Korzenik J. R., Young L., Henderson K. J., Jain D., Byrd B., Pollak J. S., White R. I., Jr Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000 Sep 28;343(13):931–936. doi: 10.1056/NEJM200009283431305. [DOI] [PubMed] [Google Scholar]
  13. Gershon A. S., Faughnan M. E., Chon K. S., Pugash R. A., Clark J. A., Bohan M. J., Henderson K. J., Hyland R. H., White R. I., Jr Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations during pregnancy. Chest. 2001 Feb;119(2):470–477. doi: 10.1378/chest.119.2.470. [DOI] [PubMed] [Google Scholar]
  14. Graf C. J., Perret G. E., Torner J. C. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983 Mar;58(3):331–337. doi: 10.3171/jns.1983.58.3.0331. [DOI] [PubMed] [Google Scholar]
  15. Haitjema T., Disch F., Overtoom T. T., Westermann C. J., Lammers J. W. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995 Nov;99(5):519–524. doi: 10.1016/s0002-9343(99)80229-0. [DOI] [PubMed] [Google Scholar]
  16. Heldin C. H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997 Dec 4;390(6659):465–471. doi: 10.1038/37284. [DOI] [PubMed] [Google Scholar]
  17. Kjeldsen A. D., Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol. 2000 Feb;95(2):415–418. doi: 10.1111/j.1572-0241.2000.01792.x. [DOI] [PubMed] [Google Scholar]
  18. Kjeldsen A. D., Oxhøj H., Andersen P. E., Elle B., Jacobsen J. P., Vase P. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest. 1999 Aug;116(2):432–439. doi: 10.1378/chest.116.2.432. [DOI] [PubMed] [Google Scholar]
  19. Kjeldsen A. D., Vase P., Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999 Jan;245(1):31–39. doi: 10.1046/j.1365-2796.1999.00398.x. [DOI] [PubMed] [Google Scholar]
  20. Lennox P. A., Harries M., Lund V. J., Howard D. J. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol. 1997 Jan;111(1):34–37. doi: 10.1017/s0022215100136370. [DOI] [PubMed] [Google Scholar]
  21. Lund V. J., Howard D. J. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol. 1997 Jan;111(1):30–33. doi: 10.1017/s0022215100136369. [DOI] [PubMed] [Google Scholar]
  22. McDonald J. E., Miller F. J., Hallam S. E., Nelson L., Marchuk D. A., Ward K. J. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet. 2000 Aug 14;93(4):320–327. doi: 10.1002/1096-8628(20000814)93:4<320::aid-ajmg12>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  23. Miller F. J., Jr, Whiting J. H., Korzenik J. R., White R. I. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Radiology. 1999 Dec;213(3):928–930. doi: 10.1148/radiology.213.3.r99nv36928. [DOI] [PubMed] [Google Scholar]
  24. Piantanida M., Buscarini E., Dellavecchia C., Minelli A., Rossi A., Buscarini L., Danesino C. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet. 1996 Jun;33(6):441–443. doi: 10.1136/jmg.33.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Plauchu H., de Chadarévian J. P., Bideau A., Robert J. M. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989 Mar;32(3):291–297. doi: 10.1002/ajmg.1320320302. [DOI] [PubMed] [Google Scholar]
  26. Porteous M. E., Burn J., Proctor S. J. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet. 1992 Aug;29(8):527–530. doi: 10.1136/jmg.29.8.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Román G., Fisher M., Perl D. P., Poser C. M. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol. 1978 Aug;4(2):130–144. doi: 10.1002/ana.410040207. [DOI] [PubMed] [Google Scholar]
  28. SMITH J. L., LINEBACK M. I. Hereditary hemorrhagic telangiectasia; nine cases in one Negro family, with special reference to hepatic lesions. Am J Med. 1954 Jul;17(1):41–49. doi: 10.1016/0002-9343(54)90142-4. [DOI] [PubMed] [Google Scholar]
  29. Saba H. I., Morelli G. A., Logrono L. A. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med. 1994 Jun 23;330(25):1789–1790. doi: 10.1056/NEJM199406233302504. [DOI] [PubMed] [Google Scholar]
  30. Sabbà C., Gallitelli M., Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med. 2001 Sep 20;345(12):926–926. doi: 10.1056/NEJM200109203451216. [DOI] [PubMed] [Google Scholar]
  31. Sagara K., Miyazono N., Inoue H., Ueno K., Nishida H., Nakajo M. Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. AJR Am J Roentgenol. 1998 Mar;170(3):727–730. doi: 10.2214/ajr.170.3.9490963. [DOI] [PubMed] [Google Scholar]
  32. Sargeant I. R., Loizou L. A., Rampton D., Tulloch M., Bown S. G. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut. 1993 Apr;34(4):470–475. doi: 10.1136/gut.34.4.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shapshay S. M., Oliver P. Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope. 1984 Dec;94(12 Pt 1):1554–1556. [PubMed] [Google Scholar]
  34. Shovlin C. L., Guttmacher A. E., Buscarini E., Faughnan M. E., Hyland R. H., Westermann C. J., Kjeldsen A. D., Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66–67. doi: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  35. Shovlin C. L., Hughes J. M., Tuddenham E. G., Temperley I., Perembelon Y. F., Scott J., Seidman C. E., Seidman J. G. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994 Feb;6(2):205–209. doi: 10.1038/ng0294-205. [DOI] [PubMed] [Google Scholar]
  36. Shovlin C. L., Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax. 1999 Aug;54(8):714–729. doi: 10.1136/thx.54.8.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shovlin C. L., Winstock A. R., Peters A. M., Jackson J. E., Hughes J. M. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM. 1995 Dec;88(12):879–887. [PubMed] [Google Scholar]
  38. Trembath R. C., Thomson J. R., Machado R. D., Morgan N. V., Atkinson C., Winship I., Simonneau G., Galie N., Loyd J. E., Humbert M. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001 Aug 2;345(5):325–334. doi: 10.1056/NEJM200108023450503. [DOI] [PubMed] [Google Scholar]
  39. Ulsø C., Vase P., Stoksted P. Long-term results of dermatoplasty in the treatment of hereditary haemorrhagic telangiectasia. J Laryngol Otol. 1983 Mar;97(3):223–226. doi: 10.1017/s0022215100094044. [DOI] [PubMed] [Google Scholar]
  40. Wallace G. M., Shovlin C. L. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax. 2000 Aug;55(8):685–690. doi: 10.1136/thorax.55.8.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Willemse R. B., Mager J. J., Westermann C. J., Overtoom T. T., Mauser H., Wolbers J. G. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000 May;92(5):779–784. doi: 10.3171/jns.2000.92.5.0779. [DOI] [PubMed] [Google Scholar]
  42. van Cutsem E., Rutgeerts P., Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet. 1990 Apr 21;335(8695):953–955. doi: 10.1016/0140-6736(90)91010-8. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES